PT - JOURNAL ARTICLE AU - Tobin, Jonathan N. AU - Weiss, Elisa S. AU - Cassells, Andrea AU - Lin, TJ AU - Carrozzi, Gianni AU - Barsanti, Franco AU - Morales, Alejandra AU - Mailing, Alison AU - Espejo, Maria AU - Gilbert, Erica AU - Casano, Louann AU - O’Hara-Cicero, Ellen AU - Weed, John AU - Dietrich, Allen J. TI - A Randomized Controlled Trial to Increase Cancer Screening and Reduce Depression among Low-Income Women AID - 10.1101/2020.11.05.20225383 DP - 2020 Jan 01 TA - medRxiv PG - 2020.11.05.20225383 4099 - http://medrxiv.org/content/early/2020/11/06/2020.11.05.20225383.short 4100 - http://medrxiv.org/content/early/2020/11/06/2020.11.05.20225383.full AB - Background Women from low-income, racial/ethnic minority backgrounds receive fewer cancer screenings than other women and have higher rates of depression, which can interfere with cancer screening participation.Objective Assess the comparative effectiveness of two interventions to improve breast, cervical, and colorectal cancer screening and reduce depression among underserved women with depressive symptoms.Design Randomized comparative effectiveness trialSetting Six Federally Qualified Health CentersParticipants N=757, 50-64 years with depression symptoms and overdue for cancer screening.Interventions Participants were randomized to collaborative depression care plus cancer screening intervention (Collaborative Care Intervention, CCI) or cancer screening intervention alone (Prevention Care Management, PCM). Both of these evidence-based, telephone interventions were delivered in English or Spanish, for up to 12 months, by care managers.Measurements Electronic Health Records provided cancer screening data (primary outcome). PHQ-9 measured depression at study entry (T0), 6- and 12-months post-baseline (T1 and T2, respectively; secondary outcome).Results Analyses revealed statistically significant increases in up-to-date status for all cancer screenings; depression improved in both intervention groups. There were no statistically significant differences between the two interventions in improving cancer screening rates or reducing depression.Limitations Depressive symptom improvement may be explained by typical symptom remission. The study duration (12-months) was insufficient to evaluate intervention effects on long-term cancer screening behavior and depression. This study was not powered for site-level analysis.Conclusions CCI and PCM both improved breast, cervical, and colorectal cancer screening and depression in clinical settings in underserved communities, however neither intervention showed an advantage in outcomes. Decisions about which approach to implement may depend on the nature of the practice and alignment of the interventions with other ongoing priorities and resources.Funding source This study was funded by Patient Centered Outcomes Research Institute (PCORI) (IH-12-11-4522) with additional infrastructure support from Agency for Healthcare Research and Quality (AHRQ) (5P30-HS-021667).Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02273206Funding StatementPatient Centered Outcomes Research Institute (PCORI) [IH-12-11-4522] with additional infrastructure support provided through Agency for Healthcare Research and Quality (AHRQ) [5P30-HS-021667].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Three IRBs approved the protocol and study materials for this trial. 1) Institutional Review Board of Clinical Directors Network (CDN), New York, New York: Approved. 2) Institutional Review Board of Montefiore Medical Center, Bronx, New York: Approved. 3) Institutional Review Board of NYC Health+Hospitals/Lincoln Hospital, Bronx, New York: Approved. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe Study Protocol (original and amendments), computer code that authors used to generate the results reported in the published article, and the documented analytic dataset will be available to approved individuals through written agreements with the lead author. Protocol: https://www.pcori.org/sites/default/files/Tobin229-Final-Research-Report.pdf. Statistical Code: Available to interested readers by contacting Dr. Tobin at jntobin@cdnetwork.org. Data: Available to interested readers by contacting Dr. Tobin at jntobin@cdnetwork.org.